Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 8(10): e78316, 2013.
Article in English | MEDLINE | ID: mdl-24250753

ABSTRACT

Apoptosis of lymphocytes governs the response of the immune system to environmental stress and toxic insult. Signaling through the ubiquitously expressed glucocorticoid receptor, stress-induced glucocorticoid hormones induce apoptosis via mechanisms requiring altered gene expression. Several reports have detailed the changes in gene expression mediating glucocorticoid-induced apoptosis of lymphocytes. However, few studies have examined the role of non-coding miRNAs in this essential physiological process. Previously, using hybridization-based gene expression analysis and deep sequencing of small RNAs, we described the prevalent post-transcriptional repression of annotated miRNAs during glucocorticoid-induced apoptosis of lymphocytes. Here, we describe the development of a customized bioinformatics pipeline that facilitates the deep sequencing-mediated discovery of novel glucocorticoid-responsive miRNAs in apoptotic primary lymphocytes. This analysis identifies the potential presence of over 200 novel glucocorticoid-responsive miRNAs. We have validated the expression of two novel glucocorticoid-responsive miRNAs using small RNA-specific qPCR. Furthermore, through the use of Ingenuity Pathways Analysis (IPA) we determined that the putative targets of these novel validated miRNAs are predicted to regulate cell death processes. These findings identify two and predict the presence of additional novel glucocorticoid-responsive miRNAs in the rat transcriptome, suggesting a potential role for both annotated and novel miRNAs in glucocorticoid-induced apoptosis of lymphocytes.


Subject(s)
Apoptosis , Glucocorticoids/physiology , Lymphocytes/physiology , MicroRNAs/genetics , Animals , Base Sequence , Cells, Cultured , Dexamethasone/pharmacology , Gene Expression Regulation , Glucocorticoids/pharmacology , High-Throughput Nucleotide Sequencing , Male , MicroRNAs/metabolism , Molecular Sequence Data , Primary Cell Culture , Rats , Rats, Sprague-Dawley , Sequence Analysis, RNA , Thymocytes/metabolism , Transcriptome
2.
Endocrinology ; 153(8): 3701-12, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22673229

ABSTRACT

Synthetic glucocorticoids are widely used for treatment of many inflammatory diseases. However, long-term glucocorticoid treatment can cause a variety of negative side effects. A genome-wide microarray analysis was performed in human lung A549 cells to identify genes regulated by both the antiinflammatory steroid dexamethasone (Dex) and the proinflammatory cytokine TNFα. Unexpectedly, we discovered that numerous genes were coregulated by treatment with both Dex and TNFα. We evaluated the mechanism of coregulation of one of these genes, serpinA3 (α-1 antichymotrypsin), a secreted, acute phase protein strongly associated with numerous inflammatory diseases. Up-regulation of serpinA3 requires the presence of both the glucocorticoid receptor and TNFα soluble receptor 1. Treatment with Dex or TNFα resulted in a 10- to 25-fold increase of serpinA3 mRNA, whereas coadministration of Dex and TNFα led to a synergistic increase in serpinA3 mRNA. The naturally occurring glucocorticoid, cortisol, also resulted in a synergistic increase in serpinA3 mRNA levels in A549 cells. Furthermore, in vivo treatment of C57BL/6 mice with Dex and TNFα resulted in coregulation of serpinA3 mRNA levels in both lung and liver tissues. Finally, chromatin immunoprecipitation analyses suggest that glucocorticoid receptor binding to the serpinA3 transcriptional start site can be enhanced by the combination of Dex plus TNFα treatment of A549 cells. These studies demonstrate that glucocorticoids and proinflammatory compounds can coregulate genes associated with human disease. This discovery may underlie the basis of some of the adverse effects associated with long-term glucocorticoid therapy.


Subject(s)
Glucocorticoids/metabolism , Glucocorticoids/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Animals , Blotting, Western , Cell Line , Chromatin Immunoprecipitation , Dexamethasone/metabolism , Dexamethasone/pharmacology , Gene Expression/drug effects , Humans , Male , Mice , Protein Binding , Real-Time Polymerase Chain Reaction , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/metabolism , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/metabolism , Serpins/genetics , Serpins/metabolism
3.
J Biol Chem ; 287(9): 6284-95, 2012 Feb 24.
Article in English | MEDLINE | ID: mdl-22228768

ABSTRACT

Apoptosis is a stochastic, physiological form of cell death that is characterized by unique morphological and biochemical properties. A defining feature of apoptosis in all cells is the apoptotic volume decrease or AVD, which has been considered a passive component of the cell death process. Most cells have inherent volume regulatory increase (RVI) mechanisms to contest an imposed loss in cell size, however T-cells are unique in that they do not have a RVI response. We utilized this property to explore potential regulatory roles of a RVI response in apoptosis. Exposure of immature T-cells to hyperosmotic stress resulted in a rapid, synchronous, and caspase-dependent apoptosis. Multiple rounds of osmotic stress followed by recovery of cells in normal media resulted in the development of a population of cells that were resistant to osmotic stress induced apoptosis. These cells were also resistant to other apoptotic stimuli that activate via the intrinsic cell death pathway, while remaining sensitive to extrinsic apoptotic stimuli. Interestingly, these osmotic stress resistant cells showed no increase in anti-apoptotic proteins, and released cytochrome c from their mitochondria following exposure to intrinsic apoptotic stimuli. The osmotic stress resistant cells developed a RVI response, and inhibition of the RVI restored sensitivity to apoptotic agents. Analysis of apoptotic signaling pathways showed a sustained increase in phospho-AKT, whose inhibition also prevented an RVI response resulting in apoptosis. These results define a critical role of volume regulation mechanisms in apoptotic resistance.


Subject(s)
Apoptosis/physiology , Lymphoma/pathology , Lymphoma/physiopathology , Stress, Physiological/physiology , T-Lymphocytes/cytology , T-Lymphocytes/physiology , Animals , Apoptosis/drug effects , Caspases/metabolism , Cell Line, Tumor , Cell Size/drug effects , Culture Media/pharmacology , Diuretics, Osmotic/pharmacology , Flow Cytometry , Homeostasis/drug effects , Homeostasis/physiology , Mannitol/pharmacology , Mice , Osmotic Pressure/drug effects , Osmotic Pressure/physiology , Signal Transduction/drug effects , Signal Transduction/physiology , Stress, Physiological/drug effects , T-Lymphocytes/drug effects
4.
Mol Endocrinol ; 26(2): 244-56, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22174376

ABSTRACT

A mutation in the D-loop of the second zinc finger of the DNA-binding domain of the human glucocorticoid receptor (hGR), A458T (GR(dim)), has been suggested to be essential for dimerization and DNA binding of the GR, and genetically altered GR(dim) mice survive, whereas murine GR knockout mice die. Interestingly, thymocytes isolated from the GR(dim) mice were reported to be resistant to glucocorticoid-induced apoptosis. To further evaluate the dim mutations in glucocorticoid-induced apoptosis, we stably expressed either the hGR(dim) (A458T) or the hGR(dim4) (A458T, R460D, D462C, and N454D) mutant receptors in human osteosarcoma (U-2 OS) cells that are devoid of hGR and unresponsive to glucocorticoids. We analyzed these cell lines by comparison with a stable expression hGRα U-2 OS cell line, which undergoes apoptosis after glucocorticoid treatment. Transient reporter gene assays with glucocorticoid response element-driven vectors revealed that the hGR(dim) mutation had diminished steroid responsiveness and cells carrying the hGR(dim4) mutation were unresponsive to steroid, whereas glucocorticoid-induced nuclear factor κB repression was unaffected by either mutation. Interestingly, both the hGR(dim) and hGR(dim4) receptors readily formed dimers as measured by immunoprecipitation. Examination of GR-mediated apoptosis showed that hGR(dim) cells were only partially resistant to apoptosis, whereas hGR(dim4) cells were completely resistant to glucocorticoid-induced cell death despite remaining sensitive to other apoptotic stimuli. Global gene expression analysis revealed that hGR(dim4) cells widely regulated gene expression but differentially regulated apoptotic mRNA when compared with cells expressing wild-type hGRα. These studies challenge conclusions drawn from previous studies of GR dim mutants.


Subject(s)
Apoptosis , Glucocorticoids/physiology , Osteocytes/physiology , Receptors, Glucocorticoid/genetics , Amino Acid Substitution , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Cell Line, Tumor , Chromatin Immunoprecipitation , Dexamethasone/pharmacology , Gene Expression Profiling , Gene Expression Regulation , Genes, Reporter , Glucocorticoids/pharmacology , Humans , Luciferases/biosynthesis , Luciferases/genetics , Oligonucleotide Array Sequence Analysis , Osteocytes/metabolism , Promoter Regions, Genetic , Protein Binding , Protein Multimerization , Protein Structure, Tertiary , Receptors, Glucocorticoid/metabolism , Signal Transduction , Transcriptional Activation
5.
Mol Endocrinol ; 25(7): 1087-99, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21527497

ABSTRACT

Glucocorticoids regulate a variety of physiological processes and are commonly used to treat disorders of inflammation, autoimmune diseases, and cancer. Glucocorticoid action is predominantly mediated through the classic glucocorticoid receptor (GR)α isoform. Recent data suggest that the mature GRα mRNA is translated into multiple N-terminal isoforms that have distinct biochemical properties and gene regulatory profiles. Interestingly, osteosarcoma cells stably expressing the GRα-D translational isoform are unique in that they are resistant to glucocorticoid-induced apoptosis. In this study, we investigate whether GRα isoform-specific differences in the regulation of antiapoptotic genes contribute to this resistant phenotype. We now show that GRα-D, unlike the other receptor isoforms, does not inhibit the activity of a nuclear factor κB (NF-κB)-responsive reporter gene and does not efficiently repress either the transcription or protein production of the antiapoptotic genes Bcl-xL, cellular inhibitor of apoptosis protein 1, and survivin. The inability of GRα-D to down-regulate the expression of these genes appears to be associated with a diminished interaction between GRα-D and NF-κB that is observed in cells, but not in vitro, and likely reflects the sequestration of GRα-D in the nucleus. Deletion of the GRα N-terminal amino acids 98-335 also results in a nuclear resident GR, which fails to interact with NF-κB in cells and promote apoptosis in response to glucocorticoids. These data suggest that the N-terminal translational isoforms of GRα selectively regulate antiapoptotic genes and that the GRα-D isoform may contribute to the resistance of certain cancer cells to glucocorticoid-induced apoptosis.


Subject(s)
Apoptosis/genetics , Dexamethasone/pharmacology , Drug Resistance, Neoplasm , Glucocorticoids/pharmacology , Inhibitor of Apoptosis Proteins/genetics , Receptors, Glucocorticoid/metabolism , Amino Acid Motifs , Caspases/metabolism , Cell Line, Tumor , Genes, Reporter , Humans , Inhibitor of Apoptosis Proteins/metabolism , Luciferases, Renilla/biosynthesis , Luciferases, Renilla/genetics , NF-kappa B/metabolism , Osteosarcoma , Promoter Regions, Genetic , Protein Binding , Protein Isoforms/metabolism , Signal Transduction , Survivin , bcl-X Protein/genetics , bcl-X Protein/metabolism
6.
Exp Cell Res ; 297(1): 212-23, 2004 Jul 01.
Article in English | MEDLINE | ID: mdl-15194437

ABSTRACT

We have examined UV irradiation-induced cell death in Jurkat cells and evaluated the relationships that exist between inhibition of caspase activity and the signaling mechanisms and pathways of apoptosis. Jurkat cells were irradiated with UV-C light, either with or without pretreatment with the pan-caspase inhibitor, z-VAD-fmk (ZVAD), or the more selective caspase inhibitors z-IETD-fmk (IETD), z-LEHD-fmk (LEHD), and z-DEVD-fmk (DEVD). Flow cytometry was used to examine alterations in viability, cell size, plasma membrane potential (PMP), mitochondrial membrane potential (DeltaPsi(mito)), intracellular Na(+) and K(+) concentrations, and DNA degradation. Processing of pro-caspases 3, 8, and 9 and the pro-apoptotic protein Bid was determined by Western blotting. UV-C irradiation of Jurkat cells resulted in characteristic apoptosis within 6 h after treatment and pretreatment of cells with ZVAD blocked these features. In contrast, pretreatment of the cells with the more selective caspase inhibitors under conditions that effectively blocked DNA degradation and inhibited caspase 3 and 8 processing as well as Bid cleavage had little protective effect on the other apoptotic characteristics examined. Thus, both intrinsic and extrinsic pathways are activated during UV-induced apoptosis in Jurkat cells and this redundancy appears to assure cell death during selective caspase inhibition.


Subject(s)
Apoptosis/radiation effects , Caspases/metabolism , Leukemia, T-Cell/metabolism , Leukemia, T-Cell/radiotherapy , Signal Transduction/radiation effects , Ultraviolet Rays , Apoptosis/physiology , BH3 Interacting Domain Death Agonist Protein , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/metabolism , Caspase 3 , Caspase 8 , Caspase 9 , Caspase Inhibitors , Cell Size/physiology , Cell Size/radiation effects , Cell Survival/physiology , Cell Survival/radiation effects , DNA Fragmentation/drug effects , Enzyme Inhibitors/pharmacology , Humans , Jurkat Cells , Leukemia, T-Cell/enzymology , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Mitochondria/physiology , Mitochondria/radiation effects , Potassium/metabolism , Protein Processing, Post-Translational/drug effects , Protein Processing, Post-Translational/radiation effects , Signal Transduction/physiology , Sodium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...